PFIZER INC Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- PFIZER INC payments for repurchase of common stock for the quarter ending 2023-12-31 was $0.00.
- PFIZER INC payments for repurchase of common stock for the quarter ending 2023-10-01 was $0.00.
- PFIZER INC payments for repurchase of common stock for the quarter ending 2023-07-02 was $0.00.
- PFIZER INC payments for repurchase of common stock for the quarter ending 2023-04-02 was $0.00, a 100.00% decline year-over-year.
- PFIZER INC payments for repurchase of common stock for fiscal 2024 was $0.00.
- PFIZER INC payments for repurchase of common stock for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- PFIZER INC payments for repurchase of common stock for fiscal 2022 was $2.00B.
- PFIZER INC payments for repurchase of common stock for fiscal 2021 was $0.00.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-27 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 |
| 2023-10-01 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $0.00 derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-07-02 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $0.00 derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-04-02 | $0.00 10-Q · filed 2023-05-10 | $0.00 derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.00B 10-K · filed 2025-02-27 |
| 2022-10-02 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $2.00B derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-07-03 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $2.00B derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-04-03 | $2.00B 10-Q · filed 2023-05-10 | $2.00B derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $0.00 10-K · filed 2024-02-22 |
| 2021-10-03 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-07-04 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $0.00 derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-04-04 | $0.00 10-Q · filed 2022-05-11 | $0.00 derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $0.00 10-K · filed 2023-02-23 |
| 2020-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $0.00 derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-29 | $0.00 10-Q · filed 2020-05-07 | $0.00 derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $8.87B 10-K · filed 2022-02-24 |
| 2019-09-29 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $13.89B derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $15.00B derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $8.87B 10-Q · filed 2020-05-07 | $15.00B derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $5.03B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $12.20B 10-K · filed 2021-02-25 |
| 2018-09-30 | $1.10B derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $7.17B derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-07-01 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $6.06B derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-04-01 | $6.06B 10-Q · filed 2019-05-09 | $6.06B derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $5.00B 10-K · filed 2020-02-27 |
| 2017-10-01 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $5.00B derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-07-02 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $5.00B derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-04-02 | $5.00B 10-Q · filed 2018-05-10 | $5.00B derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $5.00B 10-K · filed 2019-02-28 |
| 2016-10-02 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $5.00B derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-07-03 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $5.16B derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-04-03 | $5.00B 10-Q · filed 2017-05-11 | $5.16B derived: sum of 4 quarters · filed 2018-02-22 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $6.16B 10-K · filed 2018-02-22 |
| 2015-09-27 | $160.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $7.36B derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $8.48B derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-29 | $6.00B 10-Q · filed 2016-05-12 | $9.80B derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | $1.20B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $5.00B 10-K · filed 2017-02-23 |
| 2014-09-28 | $1.28B derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $8.45B derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-29 | $1.32B derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $10.92B derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-30 | $1.20B 10-Q · filed 2015-05-07 | $12.86B derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $4.65B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $16.29B 10-K · filed 2016-02-29 |
| 2013-09-29 | $3.75B derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $15.04B derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | $3.26B derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $13.12B derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | $4.63B 10-Q · filed 2014-05-08 | $11.20B derived: sum of 4 quarters · filed 2015-02-27 |
| 2012-12-31 | $3.39B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $8.23B 10-K · filed 2015-02-27 |
| 2012-09-30 | $1.83B derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $8.04B derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-07-01 | $1.34B derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $8.32B derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-04-01 | $1.66B 10-Q · filed 2013-05-10 | $9.23B derived: sum of 4 quarters · filed 2014-02-28 |
| 2011-12-31 | $3.21B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $9.00B 10-K · filed 2014-02-28 |
| 2011-10-02 | $2.11B derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $5.79B derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-07-03 | $2.25B derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $4.18B derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-04-03 | $1.43B 10-Q · filed 2012-05-10 | |
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $1.00B 10-K · filed 2013-02-28 |
| 2010-10-03 | $500.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | |
| 2009-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2010-02-26 | $0.00 10-K · filed 2010-02-26 |
| 2009-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05 | |
| 2008-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $500.00M 10-K · filed 2011-02-28 |
| 2008-09-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05 | |
| 2007-12-31 | $9.99B 10-K · filed 2010-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |